Search Results - "Verschuur, Arnaud"

Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG) by Sudour-Bonnange, Hélène, van Tinteren, Harm, Ramírez-Villar, Gema L., Godzinski, Jan, Irtan, Sabine, Gessler, Manfred, Chowdhury, Tanzina, Audry, Georges, Fuchs, Joerg, Powis, Mark, van de Ven, Cornelis P., Okoye, Bruce, Smeulders, Naima, Vujanic, Gordan M., Verschuur, Arnaud, L’Herminé-Coulomb, Aurore, de Camargo, Beatriz, de Aguirre Neto, Joaquim Caetano, Schenk, Jens Peter, van den Heuvel-Eibrink, Mary M., Pritchard-Jones, Katy, Graf, Norbert, Bergeron, Christophe, Furtwängler, Rhoikos

“…Background Among patients with nephroblastoma, those with bilateral disease are a unique population where maximising tumour control must be balanced with…”
Get full text

Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcS-crizotinib trial by Brugières, Laurence, Cozic, Nathalie, Houot, Roch, Rigaud, Charlotte, Sibon, David, Arfi-Rouche, Julia, Bories, Pierre, Cottereau, Anne S, Delmer, Alain, Ducassou, Stéphane, Garnier, Nathalie, Lamant, Laurence, Leruste, Amaury, Millot, Frédéric, Moalla, S., Morschhauser, Franck, Nolla, Marie, Pagnier, Anne, Reguerre, Yves, Renaud, Loïc, Schmitt, Anne, Simonin, Mathieu, Verschuur, Arnaud, Labouret, Nathalie Hoog, Mahier Ait-Oukhatar, Celine, Vassal, Gilles

“…Background: The French phase II AcSé-crizotinib trial aimed to evaluate the safety and efficacy of crizotinib in patients with ALK, ROS1, and MET-driven…”
Get full text

Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large cell lymphoma in children, adolescents and adult patients: results of the French AcSe-crizotinib trial by Brugières, L, Cozic, N, Houot, R, Rigaud, C, Sibon, D, Arfi-Rouche, J, Bories, P, Cottereau, AS, Delmer, A, Ducassou, S, Garnier, N, Lamant, L, Leruste, A, Millot, F, Moalla, S, Morschhauser, F, Nolla, M, Pagnier, A, Reguerre, Y, Renaud, L, Schmitt, A, Simonin, M, Verschuur, A, Hoog Labouret, N, Mahier Ait Oukhatar, C, Vassal, G

“…The French phase II AcSé-crizotinib trial aimed to evaluate the safety and efficacy of crizotinib in patients with ALK, ROS1 and MET-driven malignancies…”
Get full text

Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93‐01, 2001 and UK‐IMPORT database: A report of the SIOP‐Renal Tumor Study Group by Beek, Justine N., Hol, Janna A., Coulomb‐l'Hermine, Aurore, Graf, Norbert, Tinteren, Harm, Pritchard‐Jones, Kathy, Houwing, Maite E., Krijger, Ronald R., Vujanic, Gordan M., Dzhuma, Kristina, Schenk, Jens‐Peter, Littooij, Annemieke S., Ramírez‐Villar, Gema L., Murphy, Dermot, Ray, Satyajit, Al‐Saadi, Reem, Gessler, Manfred, Godzinski, Jan, Ruebe, Christian, Collini, Paola, Verschuur, Arnaud C., Frisk, Tony, Vokuhl, Christian, Hulsbergen‐van de Kaa, Christina A., Camargo, Beatriz, Sandstedt, Bengt, Selle, Barbara, Tytgat, Godelieve A. M., Heuvel‐Eibrink, Marry M.

“…In children, renal cell carcinoma (RCC) is rare. This study is the first report of pediatric patients with RCC registered by the International Society of…”
Get full text

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study by Di Giannatale, Angela, Dias-Gastellier, Nathalie, Devos, Annick, Mc Hugh, Kieran, Boubaker, Ariane, Courbon, Frederic, Verschuur, Arnaud, Ducassoul, Stéphane, Malekzadeh, Katty, Casanova, Michela, Amoroso, Loredana, Chastagner, Pascal, Zwaan, Christian M, Munzer, Caroline, Aerts, Isabelle, Landman-Parker, Judith, Riccardi, Riccardo, Le Deley, Marie-Cecile, Geoerger, Birgit, Rubie, Hervé

“…Abstract Purpose To assess objective response rate (ORR) after two cycles of temozolomide in combination with topotecan (TOTEM) in children with refractory or…”
Get full text

Standard of care for adult Wilms tumor? From adult urologist to pediatric oncologist. A retrospective review by Sudour-Bonnange, Hélène, Coulomb-Lherminé, Aurore, Fantoni, Jean Christophe, Escande, Alexandre, Brisse, Hervé J., Thebaud, Estelle, Verschuur, Arnaud

“…Nephroblastoma or Wilms tumor, a common embryonal tumor in children, can occasionally occur in adults. The survival of patients older than 18 years is reported…”
Get full text

Abstract 5549: Recipient-donor contradictory genotype with impact on anticancer drug pharmacogenetics after liver transplant: A deadly gift by Serdjebi, Cindy, Fanciullino, Raphaelle, Fina, Frederic, Verschuur, Arnaud, Roquelaure, Bertrand, Lacarelle, Bruno, Ouafik, L'Houcine, Ciccolini, Joseph, André, Nicolas

“…A 5-year old girl with liver transplant was scheduled for a therapy including high-dose cytarabine for her Burkitt lymphoma. Cytarabine pharmacogenetics focus…”
Get full text

Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab–irinotecan in children with low‐grade glioma? by Heng, Marie Amélie, Padovani, Laetitia, Dory‐Lautrec, Philippe, Gentet, Jean Claude, Verschuur, Arnaud, Pasquier, Eddy, Figarella‐Branger, Dominique, Scavarda, Didier, André, Nicolas

“…The association of bevacizumab and irinotecan has been shown to display a quick efficacy in low‐grade glioma (LGG), but most patients relapse within months…”
Get full text

Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease? by Padovani, Laetitia, Andre, Nicolas, Gentet, Jean Claude, Figarella Branger, Dominique, Scavarda, Didier, Verschuur, Arnaud, Chinot, Olivier, Cowen, Didier, Muracciole, Xavier

“…Medulloblastoma (MB) is the most common malignant pediatric brain tumor and a rare adulthood tumor. Twenty percent to 30% of patients relapses and displays a…”
Get full text

CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations by Ciccolini, Joseph, Evrard, Alexandre, M'Batchi, Lithaty, Pourroy, Bertrand, Mercier, Cédric, Iliadis, Athanassios, Lacarelle, Bruno, Verschuur, Arnaud, Ouafik, L'Houcine, André, Nicolas

“…We describe here the case of a 7-year old girl with lymphoma who developed life-threatening toxicities upon cytarabine plus mercaptopurine. Surprisingly,…”
Get more information

Liver biopsy versus ultrasound in methotrexate-treated psoriasis: a decision analysis by Verschuur, A C, van Everdingen, J J, Cohen, E B, Chamuleau, R A

“…Before starting methotrexate therapy for cases of recalcitrant psoriasis, a liver biopsy has been usual in order to exclude cirrhosis and moderate or severe…”
Get more information